One year follow-up of T-SPOT. TB results in treated patients with active tuberculosis Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007
Evaluation of drug resistance of patients with tuberculosis over a period of thirty years Source: Eur Respir J 2002; 20: Suppl. 38, 549s Year: 2002
Treatment outcomes of tuberculosis patients under directly observed therapy (DOT) for three years Source: Eur Respir J 2004; 24: Suppl. 48, 653s Year: 2004
3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review Source: Eur Respir J, 52 (1) 1800395; 10.1183/13993003.00395-2018 Year: 2018
A two-year post-treatment follow-up of multi-drug resistant tuberculosis cases who completed a programmatic MDR-TB management at the lung center of the Philippines – a preliminary report Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009
The experience of directly observed therapy in Esrefpasa tuberculosis dispensary for two years Source: Eur Respir J 2005; 26: Suppl. 49, 645s Year: 2005
When do we extend the treatment of tuberculosis (TB) more than 6 months? Source: Annual Congress 2007 - Clinical tuberculosis Year: 2007
Four years follow-up of exacerbations in a cohort of COPD patients: 1 year interim results (EXACO study) Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008
Surgical treatment of lung tuberculosis: our experience and results in the last 5 years Source: Eur Respir J 2005; 26: Suppl. 49, 633s Year: 2005
Multi-drug resistant tuberculosis: a retrospective analysis of cases over 10 years in a low incidence setting Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007
Serological response after tuberculosis treatment: two-years follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 468s Year: 2001
Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation Source: Eur Respir J, 50 (1) 1602505; 10.1183/13993003.02505-2016 Year: 2017
Evaluation of new smear positive tuberculosis patients 5 years after initiation of treatment under a DOTS programme Source: Annual Congress 2010 - Tuberculosis epidemiology Year: 2010
Comparison of two different cohorts of patients for multidrug-resistant tuberculosis treatment evaluation Source: Annual Congress 2006 - Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB) Year: 2006
HIV and tuberculosis co-infection: A 7 year retrospective cohort study Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015
Pulmonary thromboembolism in HIV (+) patients under 50 years old: a six year study Source: Annual Congress 2007 - Venous thromboembolic disease Year: 2007
Time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis: a prospective cohort study from urban China Source: Eur Respir J , 49 (3) 1601558; DOI: 10.1183/13993003.01558-2016 Year: 2017
The year of 2002 treatment results for soldiers with tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 646s Year: 2004
The year of 2003 treatment results for soldiers with tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 644s Year: 2005
Systematic review of shorter 2-3 months regimens for treatment of latent tuberculosis Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis Year: 2013